Emily Sammons

7PUBLICATIONS

31CO-AUTHORS

Vision scienceMajor global burdens of diseasePharmacogenomicsCardiology (incl. cardiovascular diseases)Nephrology and urology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 12, 2026

Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.

|Apr 03, 2025

Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Feb 26, 2025

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.

Emily Sammons, Louise Bowman, William Stevens

|Nov 12, 2024

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Parminder K Judge, Katherine R Tuttle, Natalie Staplin

|Sep 15, 2024

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Jul 01, 2024

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

Pageof 2

Frequent Collaborators

Jonathan Emberson

Kaitlin J Mayne

Richard Haynes

Christoph Wanner

Martin J Landray

William G Herrington

Katherine R Tuttle

David Preiss

Aldo P Maggioni

Masaomi Nangaku

Frequent Collaborators

Jonathan Emberson

Kaitlin J Mayne

Richard Haynes

Christoph Wanner